Research library / Longevity compounds
BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT · 100 older adults
Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline
C Schwarz, G Benson, N Horn, K Wurdack, U Grittner, R Schilling et al. JAMA Network Open. 2022.
- In plain language
- Twelve months of about 0.9 mg a day did not improve memory (difference -0.03; P = .47) or secondary outcomes vs placebo.
- Limits
- Low dose, one center; authors held equity in the supplier; funded by German government grants.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Spermidine
- Source
- doi.org/10.1001/jamanetworkopen.2022.13875 · PubMed 35616942 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.